Categories: Health

NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

NEW YORK, Sept. 4, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on September 4th

- Advertisement -
  • Stocks are fractionally higher Thursday morning after the S&P 500 rose about half a percentage point on Wednesday. Gains in shares of Big Tech including Alphabet and Apple fueled the rise.
  • A read of private sector payrolls today is expected to show 75,000 jobs were added last month. It precedes the non-farm payrolls report on Friday. Economists anticipate unemployment ticked higher in August to 4.3%.
  • Private Biotech firm Enveda announced its reached unicorn status. The clinical stage company is looking at a valuation of more than a billion dollars after closing its latest round of funding.

Opening Bell
Vontobel Asset Management celebrates its entry into the active ETF market with the launch of the Vontobel International Equity Active ETF (NYSE: VNIE)

- Advertisement -

Closing Bell
Fast Company celebrates the 30th anniversary of the Fast Company Innovation Festival

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2764704/NYSE_Market_Update_Sept_4.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5491917/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–biotech-enveda-raises-150-million-to-reach-unicorn-status-302546568.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 week ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago